Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 20Recruiting 8Unknown 3Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 98Head and Neck Neoplasms 91Nasopharyngeal Carcinoma 53Thyroid Neoplasms 30Mouth Neoplasms 24Thyroid Cancer, Papillary 15Carcinoma, Squamous Cell 14Carcinoma, Non-Small-Cell Lung 14Oropharyngeal Neoplasms 13Neoplasm Metastasis 13Laryngeal Neoplasms 12Neoplasms 11Uterine Cervical Neoplasms 10Colorectal Neoplasms 10Breast Neoplasms 10Thyroid Nodule 8Thyroid Diseases 7Nasopharyngeal Neoplasms 7Melanoma 7Lung Neoplasms 7Hypopharyngeal Neoplasms 7Ovarian Neoplasms 6Triple Negative Breast Neoplasms 5Sarcoma 5Recurrence 5Esophageal Neoplasms 5Endometrial Neoplasms 5Carcinoma, Renal Cell 5Thyroid Carcinoma, Anaplastic 4Stomach Neoplasms 4

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Penile Neoplasms × Head & Neck × Clear all
NCT06505551 2024-07-17

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

SCG Cell Therapy Pte. Ltd.

Phase 1/2 Not yet recruiting
66 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡